# Febuxostat

## Feburic 80mg

| 藥物代碼 | OFEB |
| :--- | :--- |
| 適應症 | Chronic hyperuricaemia where urate deposition had occurred including history or presence of tophus &/or gouty arthritis. |
| 副作用 | \(common\):■Dermatologic: Rash \(0.5% to 1.6% \)■Gastrointestinal: Nausea \(1.1% to 1.3% \)■Hepatic: Liver enzymes abnormal \(4.6% to 6.6% \)■Musculoskeletal: Arthralgia \(0.7% to 1.1% \), Gout, acute |
| 禁忌 | \(serious\)■Cardiovascular: Death, Cardiovascular, Myocardial infarction■Dermatologic: Stevens-Johnson syndrome■Hematologic: Idiopathic thrombocytopenic purpura \(less than 1% \)■Hepatic: Hepatitis \(less than 1% \), Liver failure■Immunologic: Anaphylaxis, Immune hypersensitivity reaction \(less than 1% \)■Musculoskeletal: Rhabdomyolysis■Neurologic: Cerebrovascular accident \(less than 1% \), Transient ischemic attack \(less than 1% \)■Renal: Renal failure \(less than 1% \), Tubulointerstitial nephritis■Other: Angioedema \(less than 1% \) |
| 藥物保存方式 | 室溫 |
| 用法用量 | 80 mg once daily. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 需 調 整 劑 量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | No \(Limited\) Human Data - animal data suggest low risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Potential Toxicity 無\(很少\)資料 - 避免使用 |
| 附帶說明 | Micromedex: Infant risk cannot be ruled out. |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

